Joe Newell Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Joe Newell is Chief Operations Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 113,097 shares of ATRA, which is worth approximately $1.3 Million. The most recent transaction as insider was on Nov 16, 2021, when has been sold 3,332 shares (Common Stock) at a price of $17.12 per share, resulting in proceeds of $57,044. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K

0% 3M change

0% 12M change

Total Value Held $1.3 Million

Joe Newell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 16 2021	SELL Open market or private sale	$57,044 $17.12 p/Share	3,332 Reduced 2.86%	113,097 Common Stock
Nov 15 2021	SELL Open market or private sale	$123,970 $17.71 p/Share	7,000 Reduced 5.67%	116,429 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$42,525 $12.15 p/Share	3,500 Added 2.76%	123,429 Common Stock
Sep 22 2021	SELL Open market or private sale	$178,500 $17.0 p/Share	10,500 Reduced 8.05%	119,929 Common Stock
Sep 22 2021	BUY Exercise of conversion of derivative security	$127,575 $12.15 p/Share	10,500 Added 7.45%	130,429 Common Stock
Sep 15 2021	SELL Open market or private sale	$48,641 $15.61 p/Share	3,116 Reduced 2.53%	119,929 Common Stock
Aug 30 2021	SELL Open market or private sale	$52,500 $15.0 p/Share	3,500 Reduced 2.77%	123,045 Common Stock
Aug 17 2021	SELL Open market or private sale	$30,398 $12.53 p/Share	2,426 Reduced 1.88%	126,545 Common Stock
May 18 2021	SELL Open market or private sale	$35,691 $14.55 p/Share	2,453 Reduced 1.87%	128,971 Common Stock
May 17 2021	SELL Open market or private sale	$52,500 $15.0 p/Share	3,500 Reduced 2.59%	131,424 Common Stock
Apr 05 2021	SELL Open market or private sale	$9,655 $14.74 p/Share	655 Reduced 0.48%	134,924 Common Stock
Mar 26 2021	SELL Open market or private sale	$38,491 $14.58 p/Share	2,640 Reduced 1.91%	135,579 Common Stock
Mar 15 2021	SELL Open market or private sale	$121,870 $17.41 p/Share	7,000 Reduced 4.82%	138,219 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$42,525 $12.15 p/Share	3,500 Added 2.35%	145,219 Common Stock
Mar 02 2021	SELL Open market or private sale	$27,872 $16.74 p/Share	1,665 Reduced 1.16%	141,719 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	37,715 Added 20.83%	143,384 Common Stock
Feb 08 2021	SELL Open market or private sale	$79,236 $20.39 p/Share	3,886 Reduced 3.55%	105,669 Common Stock
Jan 15 2021	SELL Open market or private sale	$131,880 $18.84 p/Share	7,000 Reduced 6.01%	109,555 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$42,525 $12.15 p/Share	3,500 Added 2.92%	116,555 Common Stock
Dec 16 2020	SELL Open market or private sale	$161,770 $23.11 p/Share	7,000 Reduced 5.83%	113,055 Common Stock
Dec 16 2020	BUY Exercise of conversion of derivative security	$42,525 $12.15 p/Share	3,500 Added 2.83%	120,055 Common Stock
Nov 17 2020	SELL Open market or private sale	$32,581 $19.77 p/Share	1,648 Reduced 1.39%	116,555 Common Stock
Nov 13 2020	SELL Open market or private sale	$140,550 $18.74 p/Share	7,500 Reduced 5.97%	118,203 Common Stock
Nov 13 2020	BUY Exercise of conversion of derivative security	$42,525 $12.15 p/Share	3,500 Added 2.71%	125,703 Common Stock

Joe Newell

Chief Operations Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Value

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA

Account